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We have previously communicated that heparin co-solubilizes the asymmetric form of acetylcholinesterase (AChE) and a dermatan sulfate 
proteoglycan from the extracellular matrix (ECM) of rat skeletal muscles. In this report we unequivocally demonstrate by biochemical and 
immunological analyses that the proteoglycan that is solubilized by heparin from rat skeletal muscle ECM corresponds to decorin. These results 
support the concept for the role of decorin in the ECM organization. 
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1. INTRODUCTION 
The extracellular matrix (ECM) is composed mainly 
of collagens, proteoglycans, and various non-col- 
lagenous glycoproteins. The assembly of these macro- 
molecules into ECMs is thought to be dependent on 
specific high affinity interactions between individual 
components. We have shown that in the ECM of rat 
skeletal muscle, the glycosaminoglycan heparin co-solu- 
bilizes the asymmetric form of acetylcholinesterase 
(AChE) and a dermatan sulfate proteoglycan [l] sug- 
gesting some kind of interaction between these ECM 
constituents. On the other hand, the asymmetric form 
of AChE have been shown to be anchored to the skele- 
tal muscle ECM through specific interactions with pro- 
teoglycans [2-31 and that these interactions are medi- 
ated via the collagen tail present in the AChE [2,11]. 
chondroitinase ABC (Sigma); Na,35S04 (carrier free) from New Eng- 
land Nuclear. Polyclonal rabbit antiserum against decorin purified 
from rat skin fibroblast [8] was a generous gift of Prof. Hans Kresse 
(Institute of Physiological Chemistry and Pathobiochemistry, Univer- 
sity of Mtinster, Germany). This antiserum was produced by injecting 
decorin core protein purified from the secretion of rat skin fibroblast 
as described [8]. Other reagents were obtained from commercial 
sources. Male Sprague-Dawley rats (220 g body wt.) were used. The 
rats were injected with 5-10 mCi of radioactive sulfate in saline. 
Animals were sacrificed after 18 h of the injection. 
2.1. Preparation of the extracellular matrix material 
A detergent-insoluble fraction enriched in ECM components from 
rat skeletal muscle was prepared as described previously [l]. 
2.2. Characterization of proteoglycans 
It has been shown that the level of expression of 
AChE [4] and the small dermatan sulfate proteoglycan 
decorin [5,12] are regulated by motor nerve activity. 
Recently it has been demonstrated that decorin binds to 
the collagen type VI [6] and the amount of decorin 
increases during myogenesis [7]. In this study we show 
that the proteoglycan that is specifically co-solubilized 
with AChE from the rat skeletal muscle ECM corre- 
spond to decorin. 
The fraction containing the heparin solubilized proteoglycan was 
diluted with 8 M urea, 0.1 M NaCl and 50 mM sodium acetate, pH 
5.8, containing protease inhibitors. The sample was applied to a 
DEAE-Sephacel column. The bound material was eluted with a pulse 
of the same above solution but containing 1.0 M NaCI. Analytical 
Sepharose CL-4B chromatography was carried out exactly as ex- 
plained [5]. Solubilized proteoglycans were determined by binding to 
CPC filters as explained previously [18]. 
2.3. Enzymatrc treatment 
Chondroitinase ABC treatment was carried out as described previ- 
ously [5]. 
2.4. SDS-PAGE anaIysis of proteoglycans and immunodetection 
2. MATERIALS AND METHODS 
The following chemicals were used: heparin from bovine lung and 
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The heparin solubilized material was electrophoresed on a 3-101 
polyacrylamide gel as described by Carlson and Wight [9]. After elec- 
trophoresis proteins were transferred to nitrocellulose, incubated in 
Blotto (20 mM Tris-HCI, pH 7.4, 0.1 M NaCl, 5% nonfat dry milk) 
at room temperature for 1 h to block nonspecific binding, and incu- 
bated with rabbit anti decorin antiserum (11100 dilution in Blotto). 
The bound antibody was visualized with affinity-purified phosphatase 
alkaline conjugated goat anti-rabbit IgG (Sigma, St. Louis, MO, 
USA). 
Immunoprecipitation of decorin was done exactly as described pre- 
viously by us [7]. 
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Fig. 1. The heparm solubilized proteoglycan correspond to a chondroitin/dermatan sulfate. The heparin solubilized radloactive material was 
chromatographed on a Sepharose CL4B in the presence of 50 mM Tris, pH 7.4, 1.0% sodium dodecyl sulfate, 0.1 M NaCl at a flow rate of 5.0 
ml/h. Solid line corresponds to the control; dashed line=after chondroitinase ABC treatment. V, and V, were calculated using Dextran blue and 
Phenol red, respectively. 
2.5. AChE acrivzry 
AChE activity was determined by the method of Ellman as ex- 
plained previously [131. AChE was assayed in the presence of 0.1 mM 
ethopropazine, a specific inhibitor of butyrylcholinesterases. 
3. RESULTS 
Incubation of isolated sulfate-labeled skeletal muscle 
ECM fraction with heparin resulted in an important 
solubilization of sulfated proteoglycans. Table I shows 
that over lo-fold of sulfated material was solubilized 
with heparin from the ECM fraction compared with the 
controls (buffer alone). The extent of solubilized mate- 
rial correspond approximately to 40% of the total sul- 
fated proteoglycans present in the rat skeletal muscle 
ECM. Table I also shown that heparin co-solubilizes 
85% of the total AChE activity solubilized by sodium 
Table I 
Heparin solubilizes sulfate labeled material and AChE activity from 
skeletal muscle extracellular matrix 
Sulfated material AChE 
Treatment CPM/g of tissue % Units/g of tissue % 
Control 2,910 9.3 0.002 5.7 
Heparin 31,340 100.0 0.030 85.7 
Aliquots from sulfate labeled rat skeletal ECM were incubated with 
buffer alone (control) or with heparin 2.0 mg/ml at 4°C for 15 min. 
At the end of the incubation the mixture was centrifuged and sulfated 
material and AChE activity was determined. The values correspond 
to the average of three determinations. Total solubilized counts by 
heparin represent about 40% of the total radioactive material present 
in the skeletal muscle ECM. 100% AChE activity correspond to the 
activity solubdized by 1.0 M NaCl. 
250 
chloride. Other glycosaminoglycans uch chondroitin 
sulfate and hyaluronic acid solubilized low levels of 
proteoglycans and AChE (data not shown). Fractiona- 
tion of the solubilized sulfated material on a Sepharose 
CL4B column indicates that the proteoglycan released 
by heparin eluted with a Kav of approximately 0.4 (Fig. 
1, closed circles). Incubation of the solubilized pro- 
teoglycan with chondroitinase ABC lyase followed by 
fractionation in the same column indicates that the pro- 
teoglycan solubilized with heparin correspond to a 
chondroitin/dermatan sulfate proteoglycan (Fig. 1, 
open circles). In order to visualize the heparin solubil- 
ized proteoglycan, an aliquot of this material was frac- 
tionated on SDS-PAGE followed by fluorography. Fig. 
2, lane 1 shows that the solubilized proteoglycan has 
75-90 kDa and was totally degraded after chondroiti- 
nase ABC treatment (Fig. 2, lane 2). The molecular 
weight and glycosaminoglycan composition of the hep- 
arin solubilized proteoglycan are very similar with the 
proteoglycan decorin previously characterized by us in 
the same tissue [lo]. 
In order to unequivocally confirm that the proteogly- 
can solubilized by heparin indeed correspond to decorin 
the solubilized sulfated material was incubated with an- 
tiserum against rat decorin. Fig. 2, lane 3 indicates that 
a 80 to 90 kDa proteoglycan was specifically im- 
munoprecipitated with this antiserum. No significant 
precipitation was observed when a nonimmune rabbit 
antiserum was used (Fig. 2, lane 4). To confirm that the 
immunoprecipitated proteoglycan is decorin we decided 
to determine the core protein size of the solubilized 
proteoglycan. To this, western blot analysis was per- 
formed. Fig. 3, lane 1 shows that after electrophoresis 
followed by transfer to nitrocellulose membrane, the 






Fig. 2. Antibodies against decorin specifically immunoprecipitated the 
proteoglycan solubilized by heparin. Lane l=the heparin solubilized 
proteoglycan was separated on a 3-10% polyacrilamide gel; lane 
2=same a lane 1 but preincubated with chondroitinase ABC: lane 
3=the solubilized material was incubated with antiserum against rat 
decorin and the immunoprecipitate s parated on the gel; lane 4=same 
as lane 3, but using a nonimmune antiserum. On the left, the molecular 
weight standards are shown (kDa). 
antiserum against rat decorin recognized a proteogly- 
can of 80-100 kDa in the heparin solubilized material. 
Correspondingly, digestion of the heparin solubilized 
material with chondroitinase ABC lyase before the elec- 
trophoresis made possible the visualization by the anti- 
bodies of a single core protein of 45 kDa characteristic 
of decorin (Fig. 3, lane 2). 
4. DISCUSSION 
The results presented in this paper unequivocally 
shows that he glycosaminoglycan heparin solubilized 
from rat skeletal muscle ECM the proteoglycan de- 
corin. The hydrodynamic characteristics, the sensitivity 
to chondroitinase ABC treatment, the molecular weight 
observed on SDS-PAGE and the recognition by specific 
antibodies indicate that the proteoglycan solubilized 
correspond to rat decorin. This result is particularly 
relevant because heparin also solubilizes from the mus- 
cle skeletal ECM the synaptic form of AChE [l]. This 
asymmetric molecular form of AChE contains 12 cata- 
lytic globular subunits together to a collagen tail [ll], 
being this latter responsible of the anchorage to the 
synaptic ECM [2]. Recently it has been shown that de- 
corin binds specifically to collagen type VI [6] suggest- 
ing the presence of specific binding sites for decorin in 
this collagen structure. We are now investigating if the 
collagen tail present in the asymmetric AChE indeed 
has binding domains for decorin. Interestingly, the ex- 
pression in skeletal muscles of both types of molecules, 
asymmetric AChE [4] and decorin [5,12] is strongly in- 
fluenced by the presence of the motor nerve. 
Decorin is found in the ECM of several tissues, in- 
cluding blood vessel walls, tendon, sclera as well as 
other interstitial tissues [13-141. In rat skeletal muscle, 
we have shown that decorin localizes at the perymisium 
as well as in the endomysium [5]. Besides collagen type 
VI, decorin binds to a variety of other proteins, includ- 
ing fibronectin [I 51, transforming growth factor-beta 
[16], as well as high affinity receptor on the surface of 
fibroblasts [17]. These observations suggest that this 
proteoglycan in a key molecule for the ECM organiza- 
tion and for the binding and/or presentation of soluble 
factors to the cell. 
The fact that heparin specifically solubilizes decorin 
and AChE from the muscle ECM might be an indica- 
tion of the mode of association of the asymmetric form 
of AChE to the neuromuscular junction. We have 
shown before that heparitinase but not chondroitinase 
ABC treatment of electric organ ECM also released 
AChE, probably by degrading a heparan sulfate pro- 
teoglycan [2]. These antecedent together with the results 
presented in this paper might be an indication of a 
complex association between different proteoglycans 







Fig. 3. The proteoglycan solubilized by heparin has a core protein with 
a mass of 45 kDa. An alicuot of the heparin solubilized material was 
separated in a 3-101 SDS-PAGE and transferred to nitrocellulose. 
This was incubated with antibodies against rat decorin and developed 
with a second phosphatase alkaline conjugated antibodies. (1) Un- 
treated sample, (2) chondroitinase ABC treated sample. On the left the 
position of molecular weight markers are indicated. 
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ecules (AChE) and glycoproteins (fibronectin) constitu- 
ents of the rat skeletal ECM. 
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